Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8335)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2022 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Luna-Cuadros MA, Chen HW, Hanif H, Ali MJ, Khan MM, Lau DTY. Risk of hepatocellular carcinoma after hepatitis C virus cure. World J Gastroenterol 2022; 28(1): 96-107 [PMID: 35125821 DOI: 10.3748/wjg.v28.i1.96] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v28/i1/96.htm |
| Number | Citing Articles |
| 1 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. Biomedicines 2023; 11(4): 1166 doi: 10.3390/biomedicines11041166
|
| 2 |
Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Hayato Kawamura, Kei Fujiwara, Shintaro Ogawa, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka. Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents. Oncology 2024; 102(7): 611 doi: 10.1159/000536154
|
| 3 |
Mona Mohamed Ibrahim Abdalla. Serum resistin and the risk for hepatocellular carcinoma in diabetic patients. World Journal of Gastroenterology 2023; 29(27): 4271-4288 doi: 10.3748/wjg.v29.i27.4271
Abstract(550) |
Core Tip(542) |
Full Article(HTML)(2132)
|
Full Article with Cover (PDF)-2755K(110)
|
Full Article (Word)-655K(42)
|
Audio-1151K(4)
|
Peer-Review Report-237K(53)
|
Answering Reviewers-100K(64)
|
Full Article (PDF)-1644K(175)
|
Full Article (XML)-387K(54)
|
Times Cited (4)
|
Total Visits (6001)
|
Open
|
| 4 |
Muhammad Atif, Muhammad Abdul Mustaan, Sadia Falak, Abdul Ghaffar, Bushra Munir. Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line. Saudi Journal of Biological Sciences 2022; 29(8): 103332 doi: 10.1016/j.sjbs.2022.103332
|
| 5 |
Dania ABUNAWAS, Amany ABBASY, Mohamed AFIFI, Mai MOAAZ, Ahmed KAMAL, Ashraf AWAAD, Basem ELSHERBINI. MYELOID-DERIVED SUPPRESSOR CELLS TWO YEARS AFTER HEPATITIS C VIRUS ERADICATION USING DIRECTLY ACTING ANTIVIRALS. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612024-004
|
| 6 |
Maria C White, Xinjun Wu, Blossom Damania. Oncogenic viruses, cancer biology, and innate immunity. Current Opinion in Immunology 2022; 78: 102253 doi: 10.1016/j.coi.2022.102253
|
| 7 |
Nathan L. Meyers, Tal Ashuach, Danielle E. Lyons, Mir M. Khalid, Camille R. Simoneau, Ann L. Erickson, Mehdi Bouhaddou, Thong T. Nguyen, G. Renuka Kumar, Taha Y. Taha, Vaishaali Natarajan, Jody L. Baron, Norma Neff, Fabio Zanini, Tokameh Mahmoudi, Stephen R. Quake, Nevan J. Krogan, Stewart Cooper, Todd C. McDevitt, Nir Yosef, Melanie Ott, Mario Poljak. Hepatitis C virus infects and perturbs liver stem cells. mBio 2023; 14(6) doi: 10.1128/mbio.01318-23
|
| 8 |
|
| 9 |
Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi. Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals. Gut and Liver 2024; 18(1): 147 doi: 10.5009/gnl220386
|
| 10 |
Nicola Pugliese, Davide Polverini, Ivan Arcari, Stella De Nicola, Francesca Colapietro, Chiara Masetti, Monica Ormas, Roberto Ceriani, Ana Lleo, Alessio Aghemo. Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life. Tropical Medicine and Infectious Disease 2023; 8(11): 502 doi: 10.3390/tropicalmed8110502
|
| 11 |
Leona Radmanić, Petra Šimičić, Kristian Bodulić, Adriana Vince, Snjezana Zidovec-Lepej. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C. Cytokine 2024; 176: 156529 doi: 10.1016/j.cyto.2024.156529
|
| 12 |
Rubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, Juan González-García, Oscar Brochado-Kith, Amanda Fernández-Rodríguez, Cristina Díez, Victor Hontañon, Salvador Resino, María Ángeles Jiménez-Sousa. Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1341612
|
| 13 |
Rushabh Gujarathi, Jeremy A. Klein, Chih-Yi Liao, Anjana Pillai. The Changing Demographics and Epidemiology of Hepatocellular Carcinoma. Clinics in Liver Disease 2024; doi: 10.1016/j.cld.2024.08.001
|
| 14 |
Rodolfo Sacco, Daryl Ramai, Raffaella Tortora, Giovan Giuseppe di Costanzo, Michela Emma Burlone, Mario Pirisi, Piera Federico, Bruno Daniele, Marianna Silletta, Paolo Gallo, Caterina Cocuzza, Maurizio Russello, Giuseppe Cabibbo, Gabriele Rancatore, Silvia Cesario, Gianluca Masi, Luca Marzi, Andrea Mega, Alessandro Granito, Giulia Pieri, Edoardo G. Giannini, Rosa Paolillo, Gennaro Gadaleta-Caldarola, Vincenzo Dadduzio, Guido Giordano, Luca Giacomelli, Simonetta Papa, Matteo Renzulli, Marcello Maida, Michele Ghidini, Mauro Borzio, Antonio Facciorusso. Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis. Cancers 2023; 15(2): 381 doi: 10.3390/cancers15020381
|
| 15 |
Naylya Djumaeva, Gulnara Akhundjanova, Leyla Djumaeva, Dilbar Urunova. Medicament testing on acupuncture points as a non-invasive diagnostic tool for determining the daily doses of sofosbuvir in patients with chronic hepatitis C virus infection. Future Journal of Pharmaceutical Sciences 2023; 9(1) doi: 10.1186/s43094-023-00514-z
|
| 16 |
Lorenzo Lani, Benedetta Stefanini, Franco Trevisani. Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic Review. Liver Cancer 2024; 13(4): 376 doi: 10.1159/000535497
|
| 17 |
Thanh Nguyen, Jason C. Mills, Charles J. Cho. The coordinated management of ribosome and translation during injury and regeneration. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1186638
|
| 18 |
Dongming Li, Donghui Cao, Yingnan Cui, Yuanlin Sun, Jing Jiang, Xueyuan Cao. The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1201085
|
| 19 |
Keri Toner, Chase D. McCann, Catherine M. Bollard. Applications of cell therapy in the treatment of virus-associated cancers. Nature Reviews Clinical Oncology 2024; 21(10): 709 doi: 10.1038/s41571-024-00930-x
|
| 20 |
Megan Rose Curtis, Rachel L. Epstein, Pamela Pei, Benjamin P. Linas, Andrea L. Ciaranello. Cost-Effectiveness of Strategies for Treatment Timing for Perinatally Acquired Hepatitis C Virus. JAMA Pediatrics 2024; 178(5): 489 doi: 10.1001/jamapediatrics.2024.0114
|
| 21 |
Kumi Ozaki, Takashi Ohtani, Tomokazu Ishida, Kouki Takahashi, Shota Ishida, Kenji Takata, Toyohiko Sakai, Shohei Higuchi, Toshifumi Gabata. Liver fibrosis estimated using extracellular volume fraction obtained from dual-energy CT as a risk factor for hepatocellular carcinoma after sustained virologic response: A preliminary case–control study. European Journal of Radiology 2023; 168: 111112 doi: 10.1016/j.ejrad.2023.111112
|
| 22 |
Shanshan Xu, Lixia Qiu, Liang Xu, Yali Liu, Jing Zhang. Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosis. Infectious Agents and Cancer 2024; 19(1) doi: 10.1186/s13027-024-00578-3
|
| 23 |
Virginia Sedeño-Monge, Francisca Sosa-Jurado, Luis Márquez-Domínguez, Paulina Cortés-Hernández, Verónica Vallejo-Ruiz, Gerardo Santos-López. Pathogens Associated with the Development of Cancer in Humans. 2024; : 71 doi: 10.1007/978-3-031-62558-9_4
|
| 24 |
Somkid Srisopa, Duangnate Pipatsatitpong, Chareeporn Akekawatchai. Association of serum lipid profile with liver fibrosis in HCV‑coinfected HIV patients on suppressive anti‑retroviral therapy. Biomedical Reports 2024; 21(4) doi: 10.3892/br.2024.1834
|
| 25 |
Shari S. Rogal, Tamar H. Taddei, Alexander Monto, Vera Yakovchenko, Heather Patton, Monica Merante, Patrick Spoutz, Linda Chia, Jennifer Yudkevich, Ayse Aytaman, Atoosa Rabiee, Binu V. John, Boris Blechacz, Cindy X. Cai, HoChong Gilles, Anand S. Shah, Heather McCurdy, Puneet Puri, Janice Jou, Khurram Mazhar, Jason A. Dominitz, Jennifer Anwar, Timothy R. Morgan, George N. Ioannou. Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project. Clinical Gastroenterology and Hepatology 2024; 22(2): 324 doi: 10.1016/j.cgh.2023.07.002
|
| 26 |
Ta-Jen Wang, Mei-Yen Chen, Yu-Chih Lin, Wen-Nan Chiu, Tung-Jung Huang, Hsu-Huei Weng. High prevalence of fatty liver and its association with metabolic syndrome among rural adults with chronic hepatitis C: Implications for primary healthcare. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-17851-0
|
| 27 |
Zhe Wang, Penghui Hu, Xiao Shan, Baochen Wang, Hui Xiong, Qiujing Yu. Antiviral Innate Immunity. Methods in Molecular Biology 2025; 2854: 237 doi: 10.1007/978-1-0716-4108-8_23
|
| 28 |
Sachin Kumar Tripathi, Apala Pal, Suchandrima Ghosh, Amit Goel, Rakesh Aggarwal, Soma Banerjee, Saumitra Das. LncRNA NEAT1 regulates HCV-induced Hepatocellular carcinoma by modulating the miR-9-BGH3 axis.
Journal of General Virology
2022; 103(12) doi: 10.1099/jgv.0.001809
|